Acquisition (Details Narrative) (10-K) - USD ($) |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Oct. 04, 2017 |
Dec. 31, 2018 |
Jun. 30, 2020 |
Dec. 31, 2019 |
Dec. 23, 2019 |
Mar. 19, 2018 |
|
| Number of shares issued in exchange for license agreement | 298,615 | |||||
| Common stock shares issued | 5,039,033 | 5,525,009 | 5,514,447 | 5,486,476 | 5,039,033 | |
| Common stock shares outstanding | 5,039,033 | 5,525,009 | 5,514,447 | 5,486,476 | 38,404,530 | 5,039,033 |
| Promet Therapeutics LLC [Member] | ||||||
| Business acquisition exchange percentage | 90.00% | |||||
| Number of shares issued in exchange for net assets | 4,535,121 | |||||
| Business acquisition acquired value | $ 1,017,342 | |||||
| Equity ownership percentage | 84.00% | |||||
| Percentage of common stock holdings held for others | 6.00% | |||||
| Voting interest | 90.00% | |||||
| Promet Therapeutics LLC [Member] | General and Administrative [Member] | ||||||
| Acquisition related transaction costs | $ 58,763 |
| X | ||||||||||
- Definition Business acquisition exchange percentage. No definition available.
|
| X | ||||||||||
- Definition Number of shares issued in exchange for license agreement. No definition available.
|
| X | ||||||||||
- Definition Percentage of common stock holdings held for others. No definition available.
|
| X | ||||||||||
- Definition Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition. No definition available.
|
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|